Abbott introduces XIENCE Sierra stent in India

New Delhi: Abbott, a global healthcare leader, has launched the XIENCE Sierra™ Everolimus Eluting Coronary Stent System in India. This latest addition to Abbott’s XIENCE™ family claims to offer a breakthrough solution for individuals battling with blocked coronary arteries, offering unmatched safety and efficacy even in the most complex cases.

The XIENCE Sierra stent marks a milestone in interventional cardiology, providing clinicians with enhanced capabilities to address complex coronary issues. Percutaneous coronary intervention (PCI), a minimally invasive procedure to restore blood flow in narrowed or blocked heart vessels, is significantly augmented with the XIENCE Sierra stent’s introduction.

One of XIENCE Sierra’s notable features is its greater range of expansion, facilitating treatment in vessels of different sizes at both ends. Its exceptional longitudinal strength ensures stability, reducing the risk of deformation and enhancing overall safety during procedures. Moreover, its ease of use empowers clinicians to address challenging anatomies with confidence, crossing through complex calcified lesions.

This advanced stent builds upon the legacy of the XIENCE family, renowned globally for its effectiveness in treating coronary artery disease. Recognized as one of the most-utilized drug-eluting stents globally, XIENCE has continually set benchmarks in interventional cardiology. With the introduction of XIENCE Sierra, Abbott boasts an improved stent design, a novel delivery system, and a range of sizes tailored to address challenging cases. Equipped with the same specialized coating that minimizes the risk of re-blockage, XIENCE Sierra upholds the impeccable safety record established by XIENCE stents through 120+ clinical trials involving over 120,000 patients. Published data further corroborates the efficacy of XIENCE in managing difficult-to-treat, narrowed lesions and catering to patients with complex clinical presentations.

Tushar Sharma, General Manager for Abbott’s vascular business in India & South Asia, emphasized the significance of XIENCE Sierra’s launch in India. He said, “We’ve launched XIENCE Sierra in India so that physicians can smoothly deliver the stent even in challenging cases.” “The innovative design and improved deliverability mean physicians can access and unblock difficult-to-treat lesions with more flexibility and precision. With the incidence of coronary artery disease on the rise in India, it’s important for us to provide technologies that help doctors optimally implant stents, so patients have the best outcomes possible.”

He further adds, ” In addition to offering next-generation stents, Abbott is helping physicians by providing technologies that enable them to implant stents most efficiently. We’ve launched AI enabled imaging tools and diagnostics to provide everything an interventional cardiologist needs to perform complex coronary interventions.”